Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.2B sold by 661 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Charles Lacey Compton III CEOFSLYFastly, Inc.Planned sale$52K 2,436 shares at $21.23 0.3% of stakeTraded Sep 8 Filed Sep 10
-
Patrick W Smith CEOAXONAxon Enterprise, Inc.Planned sale$5.1M 10,000 shares at $508.99 0.3% of stakeTraded Sep 8 Filed Sep 10
-
Olivier Pomel CEODDOGDatadog, Inc.Planned sale$18.6M 89,497 shares at $207.86 13% of stakeTraded Sep 8 Filed Sep 10
-
Renee D Gala CEOJAZZJazz Pharmaceuticals plcPlanned sale$486K 2,000 shares at $243.03 1.4% of stakeTraded Sep 8 Filed Sep 10
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $501.84 2.8% of stakeTraded Sep 9 Filed Sep 10
-
Brian E O'Toole CEOBKSYBlackSky Technology Inc.Planned sale$437K 20,000 shares at $21.83 1.8% of stakeTraded Sep 9 Filed Sep 10
-
Matthew W Calkins CEOAPPNAppian CorporationPlanned sale$1.6M 45,000 shares at $35.19 2.7% of stakeTraded Sep 8 Filed Sep 10
-
Ryan Cohlhepp CEOBCAXBicara Therapeutics Inc.Planned sale$401K 17,500 shares at $22.90 8.8% of stakeTraded Sep 8 Filed Sep 10
-
Ben Haim Shlomi CEOFROGJFrog Ltd.Planned sale$3.9M 45,700 shares at $85.35 1% of stakeTraded Sep 8 Filed Sep 10
-
John T Hall CEOINTAIntapp, Inc.Planned sale$119K 3,000 shares at $39.59 0.1% of stakeTraded Sep 8 Filed Sep 10
-
Subodh K Kulkarni CEORGTIRigetti Computing, Inc.Planned sale$1.9M 120,000 shares at $15.68 46% of stakeTraded Sep 9 Filed Sep 10
-
Marc A Stefanski CEOTFSLTFS Financial CorporationSale$173K 10,000 shares at $17.28 27% of stakeTraded Sep 8 Filed Sep 10
-
Gregory N Roberts CEOGOLDGold.com, Inc.Sale$1.9M 40,000 shares at $48.43 59% of stakeTraded Sep 8–9 Filed Sep 10
-
Timothy Archer CEOLRCXLam Research Corp.Planned sale$9.6M 30,000 shares at $319.26 2.7% of stakeTraded Sep 9 Filed Sep 10
-
Tod E. Carpenter CEODCIDonaldson Company, Inc.Sale$2.9M 31,968 shares at $91.10 9.7% of stakeTraded Sep 4 Filed Sep 10
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$1.2M 147,000 shares at $8.17 3.2% of stakeTraded Sep 8–9 Filed Sep 10
-
Michael J. Farrell CEORMDResMed Inc.Planned sale$1.1M 4,991 shares at $222.44 1.1% of stakeTraded Sep 8 Filed Sep 10
-
Srivastava Sudhir CEOSSIISS Innovations International Inc.Sale$100K 33,333 shares at $3.00 <0.1% of stakeTraded Sep 4 Filed Sep 9
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.2M 20,000 shares at $211.28 0.3% of stakeTraded Sep 4–8 Filed Sep 9
-
Yu-Hsin Lin CEOBLTEBelite Bio, IncPlanned sale$19.1M 100,435 shares at $190.00 59% of stakeTraded Sep 4–8 Filed Sep 9
-
Richard K Matros CEOSBRASabra Health Care REIT, Inc.Planned sale$4.2M 200,000 shares at $20.83 11% of stakeTraded Sep 8 Filed Sep 9
-
Jason Hulse Murray CEOPACSPACS Group, Inc.Planned sale$2.2M 51,887 shares at $43.12 0.1% of stakeTraded Sep 4–9 Filed Sep 9
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$7.2M 73,000 shares at $98.50 9.3% of stakeTraded Sep 8–9 Filed Sep 9
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$939K 3,300 shares at $284.40 0.8% of stakeTraded Sep 8 Filed Sep 9
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $499.03 2.8% of stakeTraded Sep 8 Filed Sep 9
-
LeeAnn Rohmann CEOLGCYLegacy Education Inc.Planned sale$53K 5,000 shares at $10.56 0.6% of stakeTraded Aug 10 Filed Sep 9
-
Sanjiv Patel CEORLAYRelay Therapeutics, Inc.Planned sale$913K 48,199 shares at $18.94 8.5% of stakeTraded Sep 8 Filed Sep 9
-
Abraham Ceesay CEORAPPRapport Therapeutics, Inc.Planned sale$374K 8,210 shares at $45.61 1.8% of stakeTraded Sep 8 Filed Sep 9
-
Fred Aslan CEOARTVArtiva Biotherapeutics, Inc.Planned sale$256K 23,429 shares at $10.92 1.6% of stakeTraded Sep 8 Filed Sep 9
-
Hong Q Hou CEOSMTCSemtech CorporationPlanned sale$277K 2,000 shares at $138.71 3.2% of stakeTraded Sep 4 Filed Sep 9
-
S Dustin Crone CEOCFFIC&F Financial CorporationSale$85K 900 shares at $94.41 9.7% of stakeTraded Sep 4 Filed Sep 9
-
Andrew D. Feldman CEOCBRSCerebras Systems Inc.Planned sale$7.9M 37,441 shares at $210.46 69% of stakeTraded Sep 4 Filed Sep 8
-
Mark Casale CEOESNTEssent Group Ltd.Planned sale$56K 798 shares at $70.01 <0.1% of stakeTraded Sep 3 Filed Sep 8
-
Charles Liang CEOSMCISuper Micro Computer, Inc.Planned sale$7.7M 200,000 shares at $38.59 31% of stakeTraded Sep 3–4 Filed Sep 8
-
Carmine N. Stengone CEOCTNMContineum Therapeutics, Inc.Planned sale$41K 2,500 shares at $16.46 13% of stakeTraded Sep 8 Filed Sep 8
-
Arora Ashish CEOCRCTCricut, Inc.Planned sale$336K 60,000 shares at $5.61 1.1% of stakeTraded Sep 4 Filed Sep 8
-
Ernie J Garateix CEOHRTGHeritage Insurance Holdings, Inc.Sale$88K 2,500 shares at $35.10 0.2% of stakeTraded Sep 3 Filed Sep 8
-
Eric P Hansotia CEOAGCOAGCO CorporationSale$338K 2,604 shares at $129.75 0.8% of stakeTraded Sep 4 Filed Sep 8
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.6M 9,500 shares at $489.20 2.8% of stakeTraded Sep 4 Filed Sep 8
-
James S Mahan III CEOLOBLive Oak Bancshares, Inc.Planned sale$397K 10,000 shares at $39.75 0.4% of stakeTraded Sep 3 Filed Sep 8
-
William Holmes Heissenbuttel CEORGLDRoyal Gold, Inc.Planned sale$1.9M 7,275 shares at $263.38 5.8% of stakeTraded Sep 3 Filed Sep 8
-
Thomas J McInerney CEOGNWGenworth Financial IncSale$1.1M 100,000 shares at $10.53 1.9% of stakeTraded Sep 3 Filed Sep 8
-
Eido Gal CEORSKDRiskified Ltd.Planned sale$972K 150,000 shares at $6.48 2.8% of stakeTraded Sep 4 Filed Sep 8
-
Olivier Loeillot CEORGENRepligen CorporationPlanned sale$504K 3,035 shares at $165.90 5.9% of stakeTraded Sep 4 Filed Sep 8
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$7.9M 76,500 shares at $103.12 8.9% of stakeTraded Sep 3–4 Filed Sep 8
-
Sean Desmond CEONCNOnCino, Inc.Planned sale$191K 8,064 shares at $23.66 0.7% of stakeTraded Sep 3 Filed Sep 8
-
Ryan Hicke CEOSEICSEI Investments CompanySale$4.2M 37,500 shares at $110.71 16% of stakeTraded Sep 3 Filed Sep 8
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.2M 20,000 shares at $208.24 0.3% of stakeTraded Sep 2–3 Filed Sep 4
-
Tony Xu CEODASHDoorDash, Inc.Planned sale$3.8M 16,667 shares at $230.00 92% of stakeTraded Sep 1 Filed Sep 3
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.5M 20,000 shares at $222.80 0.3% of stakeTraded Aug 31–Sep 1 Filed Sep 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.